Abstract:Molecular imaging includes proteomic, metabolic, cellular biologic process, and genetic imaging. In a narrow sense, molecular imaging means genetic imaging and can be called molecular-genetic imaging. Imaging reporter genes play a leading role in molecular-genetic imaging. There are 3 major methods of molecular-genetic imaging, based on optical, MRI, and nuclear medicine modalities. For each of these modalities, various reporter genes and probes have been developed, and these have resulted in successful transitions from bench to bedside applications. Each of these imaging modalities has its unique advantages and disadvantages. Fluorescent and bioluminescent optical imaging modalities are simple, less expensive, more convenient, and more user friendly than other imaging modalities. Another advantage, especially of bioluminescence imaging, is its ability to detect low levels of gene expression. MRI has the advantage of high spatial resolution, whereas nuclear medicine methods are highly sensitive and allow data from small-animal imaging studies to be translated to clinical practice. Moreover, multimodality imaging reporter genes will allow us to choose the imaging technologies that are most appropriate for the biologic problem at hand and facilitate the clinical application of reporter gene technologies. Reporter genes can be used to visualize the levels of expression of particular exogenous and endogenous genes and several intracellular biologic phenomena, including specific signal transduction pathways, nuclear receptor activities, and protein-protein interactions. This technique provides a straightforward means of monitoring tumor mass and can visualize the in vivo distributions of target cells, such as immune cells and stem cells. Molecular imaging has gradually evolved into an important tool for drug discovery and development, and transgenic mice with an imaging reporter gene can be useful during drug and stem cell therapy development. Moreover, instrumentation improvements, the identification of novel targets and genes, and imaging probe developments suggest that molecular-genetic imaging is likely to play an increasingly important role in the diagnosis and therapy of cancer.

Genetic Engineered Molecular Imaging Probes for Applications in Cell Therapy: Emphasis on MRI Approach.

Molecular imaging for In vivo tracking of stem cell fate

Multimodality Molecular Imaging of Stem Cells Therapy for Stroke.

Magnetic Resonance Imaging Permits In Vivo Monitoring Of Catheter-Based Vascular Gene Delivery

In Vivo Cellular Imaging for Translational Medical Research.

Longitudinal Monitoring of Stem Cell Grafts in Vivo Using Magnetic Resonance Imaging with Inducible Maga As a Genetic Reporter.

In Vivo Stem Cell Imaging

Molecular-genetic imaging based on reporter gene expression

A primer on in vivo cell tracking using MRI

Noninvasive in-vivo tracing and imaging of transplanted stem cells for liver regeneration.

Cellular magnetic resonance imaging: current status and future prospects

Applications of magnetic resonance imaging for cardiac stem cell therapy

Optical and MRI Multimodal Tracing of Stem Cells In Vivo

Molecular imaging of cell-based cancer immunotherapy.

Nanosensors for regenerative medicine

Magnetic resonance imaging of human neural stem cells in rodent and primate brain

Dual transfer of GFP gene and MGd into stem-progenitor cells: toward in vivo MRI of stem cell-mediated gene therapy of atherosclerosis

Molecular imaging in stem cell therapy for spinal cord injury.

Reporter Genes for Brain Imaging Using MRI, SPECT and PET

Molecular MRI of hematopoietic stem-progenitor cells: in vivo monitoring of gene therapy and atherosclerosis

MRI Reporter Genes for Noninvasive Molecular Imaging